Keratinocyte transglutaminase expression varies in squamous cell carcinomas. Academic Article uri icon


  • Type I transglutaminase (TGase I, keratinocyte or particulate transglutaminase) is a 92-kilodalton (kDa) protein expressed in abundance in cultured keratinocytes and in the hyperproliferative skin disorder psoriasis. To determine the expression of TGase I protein and mRNA, we studied tissue and established squamous carcinoma lines derived from different sources. Immunohistochemistry and Western blotting were used to detect TGase I protein with the B.C1 mouse monoclonal antibody. Only well-differentiated, skin-derived squamous carcinomas stained for TGase I. However, a precocious pattern of expression was seen overlying less-differentiated tumors. Compared to cultured human keratinocytes, squamous cell carcinoma (SCC) had many times less to 7.8 times more TGase I protein, greatest in the two most differentiated tumor lines 14-83 and ME-180. TGase I mRNA levels ranged from 0.010 to 0.00004 pg/microgram total RNA by reverse transcriptase-polymerase chain reaction using an internal standard. Protein expression correlated with mRNA levels in most SCC lines. When a human TGase I promoter was isolated and used to study genomic DNA, SCC1-83 was shown to have unique restriction enzyme fragments, including one indicative of methylation differences, also present within DNA from the KB line. These studies suggest that transcriptional control of TGase I gene expression in squamous carcinomas may be influenced both by cis elements in the promoter and by the degree of tumor squamous differentiation.

published proceedings

  • J Invest Dermatol

author list (cited authors)

  • Duvic, M., Nelson, D. C., Annarella, M., Cho, M., Esgleyes-Ribot, T., Remenyik, E., ... Clayman, G. L.

citation count

  • 25

complete list of authors

  • Duvic, M||Nelson, DC||Annarella, M||Cho, M||Esgleyes-Ribot, T||Remenyik, E||Ulmer, R||Rapini, RP||Sacks, PG||Clayman, GL

publication date

  • January 1994